DXCM
DEXCOM INC
Nasdaq: DXCM · San Diego, CA · Healthcare
$71.54+1.06 (+1.50%)Closed
Market Cap$27.61B
Cash$1.12Bmost recent
Runwayprofitable
P/E (TTM)34.2EPS $2.09
52-Wk Range$54.84 – $89.53
Avg Volume5.4M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$71.54-33.7%
Pipeline
Drug candidates sponsored by DXCM · ClinicalTrials.gov
Couldn't load pipeline. ClinicalTrials.gov or the backend may be unavailable.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for DXCM. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.